SCHEMBL3897481

SCHEMBL3897481

Cc1ccc(NC(Cl)Cl)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.48
CA12 O43570 1/20 0.48
MMP8 P22894 1/20 0.48
MAPT P10636 4/20 0.44
HPGD P15428 2/20 0.42
TDP1 Q9NUW8 4/20 0.42
ACHE P22303 1/20 0.42
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
ALDH1A1 P00352 3/20 0.42
LMNA P02545 1/20 0.41
RAPGEF4 Q8WZA2 1/20 0.38
CA2 P00918 1/20 0.38
POLB P06746 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
MITF O75030 1/20 0.37
HTT P42858 1/20 0.37
TP53 P04637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9501161 0.78 CA1 (0.52) CA1CA12MMP8MAPTHPGD
SCHEMBL3141077 0.76 CA1 (0.50) CA1CA12MMP8MAPTHPGD
SCHEMBL1454276 0.76 TDP1 (0.59) CA1CA12MMP8MAPTHPGD
SCHEMBL3901909 0.76 LMNA (0.44) CA1MMP8MAPTTDP1MEN1
SCHEMBL3899018 0.73 MAPT (0.56) CA1CA12MAPTHPGDTDP1
P-Xylene SCHEMBL17784277 0.73 ACHE (0.67) CA1TDP1ACHEMEN1KMT2A
SCHEMBL3908932 0.72 TDP1 (0.55) CA12MAPTHPGDTDP1MEN1
SCHEMBL23485010 0.72 CA1 (0.47) CA1CA12MMP8MAPTHPGD
SCHEMBL1003915 0.72 CA12 (0.52) CA1CA12MMP8MAPTHPGD
SCHEMBL18559184 0.72 MAPT (0.50) CA1CA12MMP8MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1431302-B1 PROCESS FOR SYNTHESIS OF ORGANOMETALLIC COMPOUNDS SEKISUI CHEMICAL CO LTD (JP) 2009-03-18 EP disclosed
US-7098355-B2 Process for synthesis of organometallic compounds SEKISUI CHEMICAL CO., LTD. (JP) 2006-08-29 US disclosed
US-20060030723-A1 Process for synthesis of organometallic compounds SEKISUI CHEMICAL CO., LTD. (JP) 2006-02-09 US disclosed
CN-1558910-A Process for synthesis of organometallic compounds ��Ԩ��ѧ��ҵ��ʽ���� 2004-12-29 CN disclosed
EP-1431302-A1 PROCESS FOR SYNTHESIS OF ORGANOMETALLIC COMPOUNDS SEKISUI CHEMICAL CO., LTD. (JP) 2004-06-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060030723-A1 Process for synthesis of organometallic compounds CYP4F12, CYP4F2, CYP4F11 CA1 3921/4885CA12 1325/4885MMP8 4669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.